Open Access
Issue
BIO Web Conf.
Volume 237, 2026
2026 8th International Conference on Biotechnology and Biomedicine (ICBB 2026)
Article Number 02002
Number of page(s) 5
Section Pharmacology, Natural Products and Drug Delivery
DOI https://doi.org/10.1051/bioconf/202623702002
Published online 10 June 2026
  • NCD Risk Factor Collaboration (NCD-RisC), Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants, Lancet 404(10467), 2077–2093 (2024). [Google Scholar]
  • W. Y. Yang, Epidemiology and trends in diabetes in China [in Chinese], Scientia Sinica Vitae 48(8), 812–819 (2018). [Google Scholar]
  • B. Zhang, W. Y. Yang, Outlook for the epidemiology and prevention of diabetes in China [in Chinese], Chinese Journal of Diabetes Mellitus 11(1), 7–10 (2019). [Google Scholar]
  • American Diabetes Association Professional Practice Committee, Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2022, Diabetes Care 45(Suppl. 1), S17–S38 (2022). [Google Scholar]
  • R. Weinberg Sibony, O. Segev, S. Dor, I. Raz, Overview of oxidative stress and inflammation in diabetes, Journal of Diabetes 16(10), e70014 (2024). [Google Scholar]
  • H. Sun, P. Saeedi, S. Karuranga, et al., IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045, Diabetes Research and Clinical Practice 183, 109119 (2022). [Google Scholar]
  • Chinese Society of Endocrinology, Chinese Diabetes Society, Consensus recommendations on utilizing glucagon-like peptide-1 (GLP-1) receptor agonists in the treatment of type 2 diabetes mellitus [in Chinese], Chinese Journal of Internal Medicine 59(11), 836–846 (2020). [Google Scholar]
  • W. Zou, Y. S. Jiang, Research progress on SGLT-2 inhibitors in the treatment of diabetic kidney disease [in Chinese], Advances in Clinical Medicine 15(1), 886–893 (2025). [Google Scholar]
  • Z. N. Gao, Application of sulfonylureas in long-term glycemic management of type 2 diabetes [in Chinese], Chinese Journal of Diabetes Mellitus 10(3), 237–240 (2018). [Google Scholar]
  • M. Foretz, B. Guigas, L. Bertrand, et al., Metformin: from mechanisms of action to therapies, Cell Metabolism 20(6), 953–966 (2014). [Google Scholar]
  • N. Xiong, S. Wei, Z. C. Hu, The research progress and trends of alpha-glucosidase inhibitors [in Chinese], Bulletin of Fermentation Science and Technology 47(1), 58–64 (2018). [Google Scholar]
  • H. Wang, J. X. Ma, M. Zhou, et al., Current advances and potential trends of the polysaccharides derived from medicinal mushrooms sanghuang, Frontiers in Microbiology 13, 965934 (2022). [Google Scholar]
  • J. Z. Chu, N. Zheng, Q. Cui, M. X. Li, Y. Li, G. C. Wu, X. H. Cheng, R. Zhang, Analyses of potential mechanism of “sanghuang” in treatment of diseases based on network pharmacology and molecular docking [in Chinese], Mycosystema 42(1), 365–382 (2023). [Google Scholar]
  • S. Zheng, S. Deng, Y. Huang, et al., Anti-diabetic activity of a polyphenol-rich extract from Phellinus igniarius in KK-Ay mice with spontaneous type 2 diabetes mellitus, Food & Function 9(1), 614–623 (2018). [Google Scholar]
  • Z. Ni, J. Li, X. Qian, et al., Phellinus igniarius polysaccharides ameliorate hyperglycemia by modulating the composition of the gut microbiota and their metabolites in diabetic mice, Molecules 28(20), 7136 (2023). [Google Scholar]
  • Z. R. Huang, Q. Z. Huang, K. W. Chen, et al., Sanghuangporus vaninii fruit body polysaccharide alleviates hyperglycemia and hyperlipidemia via modulating intestinal microflora in type 2 diabetic mice, Frontiers in Nutrition 9, 1013466 (2022). [Google Scholar]
  • D. H. Kim, B. K. Yang, S. C. Jeong, et al., Production of a hypoglycemic, extracellular polysaccharide from the submerged culture of the mushroom, Phellinus linteus, Biotechnology Letters 23(7), 513–517 (2001). [Google Scholar]
  • G. Yu, X. Fu, X. Mo, et al., Multi-target anti-diabetic styrylpyrones from Phellinus igniarius: inhibition of alpha-glucosidase, protein glycation, and oxidative stress, International Journal of Biological Macromolecules 278(Pt 2), 134854 (2024). [Google Scholar]
  • Abstracts of the 43rd European Association for the Study of Diabetes (EASD) annual meeting, 18-21 September 2007, Amsterdam, The Netherlands, Diabetologia 50(Suppl. 1), 1–538 (2007). [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.